Sparse Evidence to Support Efficacy of Traditional IBS Treatments Sparse Evidence to Support Efficacy of Traditional IBS Treatments
Traditional treatments for irritable bowel syndrome (IBS) are supported only by limited data from trials with significant risk of bias, according to a systematic review and network meta-analysis.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 10, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Medical News Today: Treatment options for IBS
Irritable bowel syndrome (IBS) is a common disorder that can significantly affect a person ’s quality of life. Learn about the treatments and remedies here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 7, 2020 Category: Consumer Health News Tags: Irritable Bowel Syndrome Source Type: news
Fecal-Microbiota Transplantation Improves IBS Symptoms Fecal-Microbiota Transplantation Improves IBS Symptoms
Fecal-microbiota transplantation (FMT) improves symptoms and quality of life in patients with irritable-bowel syndrome (IBS), researchers from Norway report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 30, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Patients With IBD Prone to Irritable Bowel Syndrome Patients With IBD Prone to Irritable Bowel Syndrome
Patients in remission from inflammatory bowel disease are susceptible to irritable bowel syndrome, but diet, cognitive therapy, and medication can help treat the symptoms.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 16, 2019 Category: Consumer Health News Tags: Gastroenterology News Source Type: news
Medical News Today: What to know about colon pain
Many factors can cause colon pain, including constipation, diarrhea, irritable bowel syndrome, and colorectal cancer. Learn more about the causes of colon pain and their treatment options here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 19, 2019 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news
Science Saturday: A 'gut-feeling' for high-risk, high-reward research
Arthur Beyder, M.D., Ph.D., runs a research laboratory at Mayo Clinic focused on examining the molecular mechanisms of gastrointestinal function and dysfunction in diseases such as irritable bowel syndrome. His goal is to discover better ways to diagnose and treat these conditions, including individualized treatment options. Using the patch-clamp technique to study the mechanical and electrical properties of sensory cells. "These [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 8, 2019 Category: Databases & Libraries Source Type: news
Medical News Today: 'Gut itch' may explain pain in IBS
New research discovers that receptors in the nervous system that cause itchy skin also reside in the gut, explaining chronic IBS pain. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 18, 2019 Category: Consumer Health News Tags: Irritable Bowel Syndrome Source Type: news
Incidence and Risk Factors for IBS in Population-based Studies Incidence and Risk Factors for IBS in Population-based Studies
This study aimed to identify the incidence and risk factors for developing new onset irritable bowel syndrome in population-based cohorts who did not have prior gastrointestinal infection.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 9, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
AstraZeneca amends collaboration with Ironwood for Linzess in China
AstraZeneca has amended its collaboration agreement with Ironwood Pharmaceuticals, Inc. (Ironwood) in China mainland, China Hong Kong and China Macau for Linzess (linaclotide), a first-in-class new treatment for patients with irritable bowel syndrome with constipation (IBS-C). (Source: World Pharma News)
Source: World Pharma News - September 19, 2019 Category: Pharmaceuticals Tags: Featured AstraZeneca Business and Industry Source Type: news
Bold Health launches new platform combining CBT, digital for gut health
Zemedy is an app targeted at treating irritable bowel syndrome symptoms through a combination of CBT, hypnotherapy exercises and stress management techniques. (Source: mobihealthnews)
Source: mobihealthnews - September 13, 2019 Category: Information Technology Source Type: news
FDA Approves Ibsrela (tenapanor) for the Treatment of Irritable Bowel Syndrome with Constipation
FREMONT, Calif., Sept. 12, 2019 /PRNewswire/ -- Ardelyx, Inc. today announced that the U.S. Food and Drug Administration has approved Ibsrela (tenapanor), a 50 mg, twice daily oral pill for the treatment of irritable bowel syndrome with constipation... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 12, 2019 Category: Drugs & Pharmacology Source Type: news
Efficacy of Fecal Microbiota Transplantation for IBS Efficacy of Fecal Microbiota Transplantation for IBS
This systemic review examined the current evidence for the efficacy of fecal microbiota transplantation in the treatment of irritable bowel syndrome.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 11, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
Cognitive Therapy by Phone, Web May Ease Irritable Bowel Symptoms
Mean IBS Symptom Severity Score reduced for telephone - , web - CBT versus treatment as usual (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - September 10, 2019 Category: Psychiatry Tags: Family Medicine, Gastroenterology, Internal Medicine, Psychiatry, Journal, Source Type: news
Cognitive Therapy by Phone, Web May Ease Irritable Bowel Symptoms
TUESDAY, Sept. 10, 2019 -- Cognitive behavioral therapy (CBT) delivered via telephone and web is effective for relieving the symptoms of irritable bowel syndrome (IBS), according to a study published online Sept. 3 in The Lancet Gastroenterology... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 10, 2019 Category: Pharmaceuticals Source Type: news
Medical News Today: IBS: Cognitive behavioral therapy more effective than standard care
New research finds that cognitive behavioral therapy may be better at reducing IBS symptoms than standard therapies 1 year after treatment. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 9, 2019 Category: Consumer Health News Tags: Irritable Bowel Syndrome Source Type: news